A refractory case of adult-onset Still’s disease

Japanese Journal of Clinical Immunology

Volumn 20, Issue 3, 1997, Pages 191-198

  Nishio, Junko ^a   Koike, Ryuji ^a   Iizuka, Hideki ^a   Nanki, Toshihiro ^a   Mizushima, Noboru ^a   Kohsaka, Hitoshi ^a   Kubota, Tetsuo ^a   Miyasaka, Nobuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adult onset Still s disease; Cyclophosphamide; Gold sodium thiomalate

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ADULT ONSET STILL DISEASE; CASE REPORT; HUMAN; MALE; MULTIDRUG RESISTANCE; REVIEW;

ADULT; ANTIRHEUMATIC AGENTS; CYCLOPHOSPHAMIDE; DRUG RESISTANCE, MULTIPLE; GOLD SODIUM THIOMALATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; STILL'S DISEASE, ADULT-ONSET;

EID: 0031160367     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.20.191     Document Type: Article

References (27)

1. Cush, J.J., Medsger, T.J., Christy, W.C. et al.: Adult - onset Still’s disease. Clinical course and outcome. Arthritis Rheum., 30: 186–194, 1987.
2. Cush, J.J., Medsger, T.J., Christy, W.C. et al.: Adult - onset Still’s disease. Clinical course and outcome. Still 163–165, 1996.
3. Kraus, A. & Alarcon, S.D.: Fever in adult onset Still’s disease. Response to methotrexate. J. Rheumatol., 18: 918–920, 1991.
4. Larson, E.B.: Adult Still’s disease. Evolution of a clinical syndrome and diagnosis, treatment, and follow-up of 17 patients. Medicine, 63: 82–91, 1984.
5. Wouters, J.M., Reekers, P., van de Putte, L. B.: Adult - onset Still’s disease. Disease course and HLA associations. Arthritis Rheum., 29: 415–418, 1986.
6. A.J., Reginato, H.J., Schumacher, D.G., Baker, et al., Adult onset Still’s disease: Experience in 23 patients and literature review with emphasis on organ failure, [Review]. Semin. Arthritis Rheum., (1987), 17, 39-57
7. A., Ohta, M., Yamaguchi, T., Tsunematsu, et al., Adult Still’s disease: A multicenter survey of Japanese patients, J. Rheumatol., (1990), 17, 1058-1063
8. J., Pouchot, J.S., Sampalis, F., Beaudet, et al., Adult Still’s disease: Manifestations, disease course and outcome in 62 patients, Medicine, (1991), 70, 118-136
9. Bourgeois, P.K.M.: Low dose methotrexate for Still’s disease in adults (abstr). Clin. Exp. Rheumatol., suppl. 2: 123, 1987.
10. Aydintug, A.O., D’Cruz, D., Cervera, R. et al.: Low dose methotrexate treatment in adult Still’s disease. J. Rheumatol., 19: 431–435, 1992.
11. Sato, M., Takeda, A., Honzu, H. et al.: Adult Still’s disease with Sjögren’s syndrome successfully treated with intravenous pulse methylprednisolone and oral cyclophosphamide. Intern. Med., 32: 730–732, 1993.
12. Chaouat, D., Belange, G., Gompel, H.: Efficite des bolus de cyclophophmide dans la maladie de Still del’adulte. Une observation. Revue du Rheumatisme et des Maladies Osteo Articulaires, 59: 285–287, 1992.
13. Falkenbach, A., Lembcke, B., Schneider, M. et al.: Polyserositis in adult Still’s disease with onset during pregnancy. Clin. Rheumatol., 13: 513–517, 1994.
14. Lipsky, P.E. & Ziff, M.: Inhibition of antigen -and mitogen-induced human lymphocyte proliferation by gold compounds. J. Clin Invest., 59: 455–466, 1977.
15. Wolf, R.E. & Hall, V.C.: Inhibition of in vitro proliferative response of cultured T lymphocytes to interleukin-2 by gold sodium thiomalate. Arthritis Rheum., 31: 176–181, 1988.
16. C.K., Mirabelli, C.P., Sung, D.H., Picker, et al., Effect of metal containing compounds on superoxide release from phorbol myristate acetate stimulated murine peritoneal macrophages: Inhibition by auranofin and spiroger-manium, J. Rheumatol., (1988), 15, 1064-1069
17. Littman, B.H. & Schwartz, P.: Gold inhibition of the production of the second complement component by lymphokine-stimulated human monocytes. Arthritis Rheum., 25: 288–296, 1982.
18. Littman, B.H., Carlson, P.L., Loose, L.D. et al.: Effects of gold sodium thiomalate and tenidap sodium (CP-66, 248–242) on a model of macrophage differentiation using HL-60 cells. Arthritis Rheum., 33: 29–36, 1990.
19. Koike, R., Miki, I., Otoshi, M. et al.: Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells. Mol. Pharmacol., 46: 599–604, 1994.
20. Yang, J.P., Merin, J.P., Nakano, T. et al.: Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. FEBS Lett., 361: 89–96, 1995.
21. Handel, M.L., Watts, C.K., deFazio, A. et al.: Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. Proc. Natl. Acad. Sci. U.S.A., 92: 4497–4501, 1995.
22. Bjerkhoel, F. & Forre, O.: Cyclosporin treatment of a patient with severe systemic juvenile rheumatoid arthritis. Scand. J. Rheumatol., 17: 483–486, 1988.
23. Bjerkhoel, F. & Forre, O.: Cyclosporin treatment of a patient with severe systemic juvenile rheumatoid arthritis. DIC Still 34: 147–152, 1993.
24. Shojania, K., Chalmers, A. & Rangno, K.: Cyclosporin A in the treatment of adult Still’s disease. J. Rheumatol., 22: 1391–1392, 1995.
25. W., Pernice, L., Schuchmann, J., Dippell, et al., Therapy f or systemic juvenile rheumatoid arthritis with gamma-interferon: A pilot study of nine patients, Arthritis Rheum., (1989), 32, 643-646
26. Silverman, E.D., Laxer, R.M., Greenwald, M. et al.: Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis. Arthritis Rheum., 33: 1015–1022, 1990.
27. Elkon, K.B., Hughes, G.R., Bywaters, E.G. et al.: Adult-onset Still’s disease. Twenty-year followup and further studies of patients with active disease. Arthritis Rheum., 25: 647–654, 1982.